Back to Trades
Trimarchi Thomas
President and CFOCIK 0002030813
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 7
- Buy transactions
- 0
- Sell transactions
- 7
- Companies
- 1
- Active
- 2025–2026
Trimarchi Thomas, President and CFO, has filed 7 SEC reports (2025–2026), all concentrated in BridgeBio Pharma, Inc. (BBIO), totaling $11.9M in disclosed volume. Weighing $0 bought versus $5.1M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
7 loaded
| Aug 18 | BBIO BridgeBio Pharma, Inc. | Trimarchi Thomas | President and CFO | Tax withheld | $1.8M |
| Mar 20 | BBIO BridgeBio Pharma, Inc. | Trimarchi Thomas | President and CFO | Grant | $0 |
| Feb 18 | BBIO BridgeBio Pharma, Inc. | Trimarchi Thomas | President and CFO | Sell | $1.0M |
| Dec 16 | BBIO BridgeBio Pharma, Inc. | Trimarchi Thomas | President and CFO | Tax withheld | $1.0M |
| Nov 18 | BBIO BridgeBio Pharma, Inc. | Trimarchi Thomas | President and CFO | Sell | $1.1M |
| Aug 22 | BBIO BridgeBio Pharma, Inc. | Trimarchi Thomas | Insider | Sell | $2.1M |
| Aug 19 | BBIO BridgeBio Pharma, Inc. | Trimarchi Thomas | Insider | Sell | $871.7K |
7 filings